Author details

Full Name

Otavia L Caballero

Affiliation

Ludwig Institute for Cancer Research Ltd.

ORCID

Career Start Year

1993

Papers

111

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37258518	ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas' disease.	NPJ Vaccines	2023
35977933	Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein.	Nat Commun	2022
34066908	Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events.	Cancers (Basel)	2021
33747357	The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy.	Oncotarget	2021
28540335	NY-ESO-1 expression in DCIS: A new predictor of good prognosis.	Oncoscience	2017
29142905	P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring.	Oncoscience	2017
27045022	Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.	Cancer Immunol Res	2016
26514153	Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro.	Stem Cell Rev Rep	2016
27846394	Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP.	Cancer Cell	2016
26244168	Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.	Oncoscience	2015
24699824	Vaccines and early breast cancer.	Cell Cycle	2014
24797829	CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage.	J Neurooncol	2014
24764584	Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers.	Cancer Immunol Res	2014
23444225	Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.	Clin Cancer Res	2013
25593980	Expression of Cancer/Testis genes in ductal carcinoma in situ and benign lesions of the breast.	Oncoscience	2013
24777967	NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches.	Cancer Immunol Res	2013
24340093	Centrosomal localisation of the cancer/testis (CT) antigens NY-ESO-1 and MAGE-C1 is regulated by proteasome activity in tumour cells.	PLoS One	2013
24277834	Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.	Proc Natl Acad Sci U S A	2013
24119551	Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors.	BMC Med Genomics	2013
24194746	A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells.	Front Genet	2013
23625514	Effects of CT-Xp gene knock down in melanoma cell lines.	Oncotarget	2013
23623661	Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.	Cancer Cell	2013
23712428	Depletion of stromal cells expressing fibroblast activation protein-Î± from skeletal muscle and bone marrow results in cachexia and anemia.	J Exp Med	2013
22156296	Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer.	Genome Res	2012
25057858	The Hippo signaling pathway and translational opportunities for brain cancers.	CNS Oncol	2012
23390371	MAGE-A3 is highly expressed in a subset of colorectal cancer patients.	Cancer Immun	2012
23133577	Differential evolution of MAGE genes based on expression pattern and selection pressure.	PLoS One	2012
22618028	Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.	Mol Cancer Res	2012
22427632	Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.	J Immunol	2012
22102544	Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile.	Stem Cells	2012
21242976	Activation of nuclear factor-kappa B signalling promotes cellular senescence.	Oncogene	2011
22110734	Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines.	PLoS One	2011
21766840	Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA.	ACS Chem Biol	2011
21437249	Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers.	PLoS One	2011
21493686	Distinct patterns of somatic alterations in a lymphoblastoid and a tumor genome derived from the same individual.	Nucleic Acids Res	2011
20082476	Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.	World J Gastroenterol	2010
21108794	Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing.	Genome Biol	2010
20862285	Frequent MAGE mutations in human melanoma.	PLoS One	2010
20528248	Number of expressed cancer/testis antigens identifies focal adhesion pathway genes as possible targets for multiple myeloma therapy.	Leuk Lymphoma	2010
20642837	Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.	Breast Cancer Res	2010
18838390	CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens.	Nucleic Acids Res	2009
19956396	Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes.	Transl Oncol	2009
19651608	CT-X antigen expression in human breast cancer.	Proc Natl Acad Sci U S A	2009
19705800	Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.	Cancer Immun	2009
19719775	Cancer/testis (CT) antigens: potential targets for immunotherapy.	Cancer Sci	2009
19805368	Bioinformatics construction of the human cell surfaceome.	Proc Natl Acad Sci U S A	2009
19181860	Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line.	Proc Natl Acad Sci U S A	2009
19171422	SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis.	Cancer Lett	2009
19211183	Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myeloma.	Exp Hematol	2009
17685455	E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer.	Head Neck	2008

1 - 50 of 111

Xinmin Li

University of California los angeles

Career Start Year 2008

Number of shared co-authors 1

Jianmin Wang

Roswell Park Comprehensive Cancer Center

Career Start Year 2003

Number of shared co-authors 2

Jonathan K Killian

From Foundation Medicine

Career Start Year 1999

Number of shared co-authors 0

Paul T Spellman

Oregon Health & Science University Hospital.

Career Start Year 1998

Number of shared co-authors 8

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 1

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1997

Number of shared co-authors 3

Benedikt Brors

German Cancer Research Center (DKFZ)

Career Start Year 1997

Number of shared co-authors 4

David Cogdell

The University of Texas MD Anderson Cancer Center

Career Start Year 1996

Number of shared co-authors 4

Agnes Viale

Memorial Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 1

Alexei Protopopov

The University of MD Anderson Cancer Center

Career Start Year 1995

Number of shared co-authors 5

Michael R Emmert-Buck

The Francis Crick Institute

Career Start Year 1994

Number of shared co-authors 1

Phillip Buckhaults

University of South Carolina

Career Start Year 1993

Number of shared co-authors 0

Holger S??ltmann

German Cancer Research Center (DKFZ)

Career Start Year 1993

Number of shared co-authors 1

Wenbin Wei

Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield

Career Start Year 1991

Number of shared co-authors 2

Phillip A Futreal

The University of Texas MD Anderson Cancer Center

Career Start Year 1991

Number of shared co-authors 7

Fredrik Pont??n

Uppsala University

Career Start Year 1991

Number of shared co-authors 3

Sean M Grimmond

The University of Melbourne

Career Start Year 1990

Number of shared co-authors 12

Abdel G Elkahloun

National Human Genome Research Institute

Career Start Year 1990

Number of shared co-authors 2

Luigi Marchionni

Weill-Cornell School of Medicine

Career Start Year 1989

Number of shared co-authors 10

Suzanne Kamel-Reid

Toronto General Hospital, University Health Network, University of Toronto

Career Start Year 1988

Number of shared co-authors 1

Mark A Watson

Washington University School of Medicine

Career Start Year 1987

Number of shared co-authors 2

Eivind Hovig

Center for Bioinformatics, University of Oslo

Career Start Year 1987

Number of shared co-authors 4

Silvano Bosari

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Career Start Year 1986

Number of shared co-authors 0

Peter Lichter

German Cancer Research Center (DKFZ)

Career Start Year 1986

Number of shared co-authors 3

Olli Kallioniemi

Karolinska Institute

Career Start Year 1984

Number of shared co-authors 2

David D L Bowtell

Peter MacCallum Cancer Centre

Career Start Year 1983

Number of shared co-authors 5

Edison T Liu

USA The Jackson Laboratory Cancer Center

Career Start Year 1982

Number of shared co-authors 6

Colin S Cooper

Norwich Medical School, University of East Anglia

Career Start Year 1978

Number of shared co-authors 1

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 8

Paul S Meltzer

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1970

Number of shared co-authors 9

row(s) 1 - 30 of 30